LivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
Follow LIVN
LivaNova PLC (LIVN) P/E ratio
As of 16 October 2026, LivaNova PLC (LIVN) trades at a P/E ratio of 22.5×. Over the past ten years it has ranged from 0.0× (March 2026) to 1,073× (October 2023); the current reading is higher than 82% of that period. That is in line with the Medical Devices industry median of 23.2× and in line with the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 39.9× | (74.72%) |
| FY2023 | 158× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.8× | (26.13%) |
| Mar 2026 | 32.3× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 44 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BRKR Bruker Corporation compare | n/m |
| BFLY Butterfly Network, Inc. compare | n/m |
| NEOG Neogen Corporation compare | n/m |
| IRTC iRhythm Holdings, Inc. compare | n/m |
| TMDX TransMedics Group, Inc. compare | 16.0× |
| LIVN LivaNova PLC | 22.5× |
| UFPT UFP Technologies, Inc. compare | 31.2× |
| ITGR Integer Holdings Corporation compare | 34.3× |
| HAE Haemonetics Corporation compare | 57.7× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)